| Dr Reddys Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 83.40 | 83.40 | 83.30 | 83.20 | 83.20 |
| Reserves | 28,773.20 | 24,157.40 | 20,517.80 | 18,413.10 | 17,097.20 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | -126.90 | -160.10 | -196.70 |
| Total Shareholders Funds | 28,856.60 | 24,240.80 | 20,474.20 | 18,336.20 | 16,983.70 |
| Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured Loans | 3,492.90 | 792.90 | 50.80 | 2,205.40 | 1,214.50 |
| Total Debt | 3,492.90 | 792.90 | 50.80 | 2,205.40 | 1,214.50 |
| Other Liabilities | 190.60 | 114.80 | 93.10 | 94.60 | 67.90 |
| Total Liabilities | 32,540.10 | 25,148.50 | 20,618.10 | 20,636.20 | 18,266.10 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 17,714.80 | 16,297.20 | 15,136.60 | 13,349.10 | 12,345.00 |
| Less: Accumulated Depreciation | 9,482.40 | 8,708.10 | 7,941.30 | 7,198.60 | 6,500.70 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 8,232.40 | 7,589.10 | 7,195.30 | 6,150.50 | 5,844.30 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 2,196.80 | 1,211.00 | 924.40 | 1,200.30 | 900.80 |
| Investments | 13,193.50 | 7,320.60 | 7,440.00 | 4,936.70 | 4,649.20 |
| Current Assets, Loans & Advances | |||||
| Inventories | 4,575.80 | 4,018.90 | 3,043.00 | 3,347.80 | 2,819.70 |
| Sundry Debtors | 5,959.00 | 4,623.90 | 4,288.90 | 4,945.40 | 4,080.00 |
| Cash and Bank Balance | 976.80 | 1,216.90 | 645.80 | 2,030.50 | 1,646.50 |
| Loans and Advances | 2,108.40 | 3,838.30 | 1,512.80 | 1,255.20 | 1,141.00 |
| Total Current Assets | 13,620.00 | 13,698.00 | 9,490.50 | 11,578.90 | 9,687.20 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 4,816.50 | 4,399.40 | 4,112.30 | 3,537.20 | 3,064.80 |
| Provisions | 418.90 | 395.30 | 305.20 | 322.20 | 298.70 |
| Total CL & Provisions | 5,235.40 | 4,794.70 | 4,417.50 | 3,859.40 | 3,363.50 |
| Net Current Assets | 8,384.60 | 8,903.30 | 5,073.00 | 7,719.50 | 6,323.70 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 94.50 | 95.10 | 0.00 | 441.60 | 582.10 |
| Deferred Tax Liability | 609.90 | 511.20 | 339.20 | 422.20 | 327.30 |
| Net Deferred Tax | -515.40 | -416.10 | -339.20 | 19.40 | 254.80 |
| Other Assets | 1,048.20 | 540.60 | 324.60 | 609.80 | 293.30 |
| Total Assets | 32,540.10 | 25,148.50 | 20,618.10 | 20,636.20 | 18,266.10 |
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |